Nordea Investment Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-62,403
Closed -$209K 948
2023
Q3
$209K Hold
62,403
﹤0.01% 954
2023
Q2
$476K Sell
62,403
-49,117
-44% -$374K ﹤0.01% 910
2023
Q1
$1.12M Sell
111,520
-4,889
-4% -$49.2K ﹤0.01% 766
2022
Q4
$1.36M Buy
116,409
+2,575
+2% +$30.2K ﹤0.01% 723
2022
Q3
$2.43M Sell
113,834
-584
-0.5% -$12.5K ﹤0.01% 649
2022
Q2
$3.47M Sell
114,418
-901
-0.8% -$27.3K 0.01% 615
2022
Q1
$4.82M Buy
115,319
+1,578
+1% +$66K 0.01% 592
2021
Q4
$5.15M Buy
113,741
+1,367
+1% +$61.9K 0.01% 579
2021
Q3
$5.86M Buy
112,374
+1,236
+1% +$64.5K 0.01% 577
2021
Q2
$7M Buy
111,138
+9,494
+9% +$598K 0.01% 517
2021
Q1
$9.38M Sell
101,644
-2,048
-2% -$189K 0.01% 387
2020
Q4
$9.29M Sell
103,692
-2,289
-2% -$205K 0.01% 375
2020
Q3
$11.1M Sell
105,981
-104,145
-50% -$10.9M 0.02% 323
2020
Q2
$16.2M Buy
210,126
+105,251
+100% +$8.1M 0.02% 345
2020
Q1
$5.76M Buy
104,875
+4,438
+4% +$244K 0.01% 386
2019
Q4
$5.5M Buy
100,437
+29,883
+42% +$1.64M 0.01% 456
2019
Q3
$3.61M Buy
70,554
+500
+0.7% +$25.6K 0.01% 628
2019
Q2
$3.39M Sell
70,054
-74,574
-52% -$3.6M 0.01% 645
2019
Q1
$7.31M Buy
144,628
+3,308
+2% +$167K 0.02% 448
2018
Q4
$8.38M Sell
141,320
-3,246
-2% -$192K 0.02% 399
2018
Q3
$9.52M Sell
144,566
-15,409
-10% -$1.01M 0.02% 410
2018
Q2
$8.08M Buy
159,975
+53,114
+50% +$2.68M 0.02% 372
2018
Q1
$5.63M Buy
106,861
+49,170
+85% +$2.59M 0.01% 421
2017
Q4
$2.68M Sell
57,691
-2,315
-4% -$108K 0.01% 540
2017
Q3
$2.43M Sell
60,006
-2,076
-3% -$84K 0.01% 562
2017
Q2
$2.11M Buy
62,082
+13,379
+27% +$454K 0.01% 558
2017
Q1
$1.41M Buy
48,703
+6,636
+16% +$193K ﹤0.01% 720
2016
Q4
$1.38M Sell
42,067
-1,899
-4% -$62.3K ﹤0.01% 616
2016
Q3
$1.39M Buy
43,966
+29,193
+198% +$920K ﹤0.01% 542
2016
Q2
$415K Buy
14,773
+10,976
+289% +$308K ﹤0.01% 791
2016
Q1
$138K Sell
3,797
-403
-10% -$14.6K ﹤0.01% 873
2015
Q4
$168K Hold
4,200
﹤0.01% 771
2015
Q3
$120K Hold
4,200
﹤0.01% 842
2015
Q2
$138K Buy
+4,200
New +$138K ﹤0.01% 793